Piscataway, NJ, September 25, 2023–Camber Pharmaceuticals is pleased to announce the addition of Olanzapine for Injection to its current portfolio.
Olanzapine for Injection is an atypical antipsychotic drug indicated for the treatment of acute agitation associated with schizophrenia and bipolar I mania.
Olanzapine for Injection 10mg is available in a carton containing one Single Dose Vial.
To find out more about Olanzapine for Injection 10 mg, please visit www.camberpharma.com
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected]
- Camber Pharmaceuticals Launches Generic Pepcid®
- Camber Pharmaceuticals Launches Generic Wellbutrin SR®
- Camber Pharmaceuticals Launches Generic Inspra®
- Camber Pharmaceuticals Launches Generic Prezista®
- Camber Pharmaceuticals Launches Generic Neurontin Caps®
- Camber Pharmaceuticals Launches Generic Zyprexa®